Conference Coverage

Ask depressed patients about hypersomnia to screen for mixicity

Publish date: November 9, 2018

 

REPORTING FROM THE ECNP CONGRESS

The BRIDGE-II-MIX study was sponsored by Sanofi-Aventis. Dr. Murru reported having no financial conflicts of interest regarding the study.

Pages

Recommended Reading

For most veterans with PTSD, helping others is a lifeline
MDedge Internal Medicine
Low and high BMI tied to higher postpartum depression risk
MDedge Internal Medicine
Most Americans incorrectly identify homicide as more common than suicide
MDedge Internal Medicine
FDA panels vote no on opioid-containing drug for MDD
MDedge Internal Medicine
Interacting with horses helps veterans with PTSD; Identical twin battles anorexia
MDedge Internal Medicine
FDA panels back brexanolone infusion for postpartum depression
MDedge Internal Medicine
Novel theory explains SSRIs’ variable efficacy
MDedge Internal Medicine
Identifying and stopping a likely mass shooter: A case study
MDedge Internal Medicine
Lay counseling effective for reducing late-life depression
MDedge Internal Medicine
Physical activity tied to lower depression risk among older adults
MDedge Internal Medicine